Synopsis : Indian equities declined on Friday as US President Trump’s 100% tariff on branded and patented pharma imports rattled sentiment. Pharma stocks dragged indices lower, while metals and media provided some relief.
The Indian stock market witnessed sharp declines on Friday, with pharma stocks bearing the brunt after US President Donald Trump announced sweeping tariffs on pharmaceutical imports. Beginning October 1, 2025, the United States will impose a 100% duty on branded or patented drugs, alongside a 25% levy on heavy trucks and a 50% tariff on kitchen cabinets and associated products.
At 11:00 AM, the BSE Sensex was at 80,786, down 373 points or 0.46%, while the NSE Nifty50 slipped 110 points or 0.45% to trade at 24,780.
On the BSE, Sun Pharma emerged as the top loser, followed by Bajaj Finance and Asian Paints. On the other hand, L&T, BEL, and Tata Steel stood out as gainers amid the broader decline.
The Nifty Pharma index plunged over 2%, reflecting the direct hit from Trump’s policy announcement. Meanwhile, Nifty Media (+0.62%) and Nifty Metal (+0.28%) were the only sectoral indices trading in positive territory.
Broader markets also traded weak. The Nifty MidCap 100 index slipped 0.21%, while the Nifty SmallCap 100 dropped 0.37%, underscoring the cautious investor sentiment.
Analysts believe the tariff shock could disrupt global pharma supply chains and weigh heavily on Indian drugmakers, who rely significantly on exports to the US market.
Disclaimer : This article is for informational purposes only and should not be considered financial advice. Investors should consult professional financial advisors before making any investment decisions.
